SPAC Overview
Timeline Progress
About
FS Development Corp. is a blank-check company formed to effect a merger, acquisition, or similar business combination with an unidentified business. It intends to capitalize on its management’s background and experience to identify opportunities in the biotechnology sector, with a primary focus on U.S. healthcare.
Investment Focus
Biopharmaceuticals
Geographic Focus
United States
The terms and the filing trail behind FS Development Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The team includes Foresite Capital co-founder Jim Tananbaum, healthcare and life-sciences investors and executives, and experienced leaders in biotechnology, healthcare investment banking, and drug development. Foresite Capital reports a substantial biotechnology investment and financing history.